YKL-40, a novel marker of disease activity in rheumatoid arthritis: the NEO-RACo study

Vaananen T.; Vuolteenaho K.; Kautiainen H.; Nieminen R.; Mottonen T.; Hannonen P.; Korpela M.; Kauppi M.; Kaipiainen-Seppanen O.; Luosujarvi R.; Leirisalo-Repo M.; Moilanen E.

首页> 外文期刊>Scandinavian journal of rheumatology >YKL-40, a novel marker of disease activity in rheumatoid arthritis: the NEO-RACo study

【24h】

YKL-40, a novel marker of disease activity in rheumatoid arthritis: the NEO-RACo study

机译：YKL-40，类风湿关节炎疾病活动的新标志物：NEO-RACo研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Scandinavian journal of rheumatology》 |2015年第6期|共1页
作者
Vaananen T.; Vuolteenaho K.; Kautiainen H.; Nieminen R.; Mottonen T.; Hannonen P.; Korpela M.; Kauppi M.; Kaipiainen-Seppanen O.; Luosujarvi R.; Leirisalo-Repo M.; Moilanen E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. YKL-40, a novel marker of disease activity in rheumatoid arthritis: the NEO-RACo study [J] . Vaananen T., Vuolteenaho K., Kautiainen H., Scandinavian journal of rheumatology . 2015,第6期

机译：YKL-40，类风湿关节炎疾病活动的新标志物：NEO-RACo研究
2. Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity [J] . Ritva Peltomaa, Leena Paimela, Sheryl Harvey, Rheumatology International . 2001,第5期

机译：早期类风湿关节炎患者血清中YKL-40水平升高：疾病活动的新标志
3. The impact of obesity on inflammatory markers used in the assessment of disease activity in rheumatoid arthritis – a?cross-sectional study [J] . Ashish Sharma, Ashok Kumar, Alka Jha, Reumatologia . 2020,第1期

机译：肥胖对类风湿性关节炎疾病活性评估中使用的炎症标志物的影响 - a？横截面研究
4. Deep radiomic prediction with clinical predictors of the survival in patients with rheumatoid arthritis-associated interstitial lung diseases [C] . Radin A. Nasirudin, Janne J. Nappi, Chinatsu Watari, SPIE Medical Imaging Conference . 2018

机译：类风湿关节炎相关性间质性肺疾病患者的深部放射学预测和生存期的临床预测
5. Measuring disease activity and use of complementary and alternative medicine in African-Americans with Rheumatoid Arthritis. [D] . Tamhane, Ashutosh. 2012

机译：测量非裔美国人类风湿关节炎的疾病活动以及补充和替代药物的使用。
6. Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial [O] . Tuija Väänänen, Katriina Vuolteenaho, Hannu Kautiainen, -1

机译：糖蛋白YKL-40：类风湿性关节炎在用csDMARDs和英夫利昔单抗强化治疗期间疾病活动的潜在生物标志物。随机对照NEO-RACo试验的证据
7. Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial [O] . Väänänen, Tuija, Vuolteenaho, Katriina, Kautiainen, Hannu, 2017

机译：糖蛋白YKL-40：类风湿关节炎在用csDMARDs和英夫利昔单抗强化治疗期间疾病活动的潜在生物标志物。随机对照NEO-RACo试验的证据

YKL-40, a novel marker of disease activity in rheumatoid arthritis: the NEO-RACo study

著录项

相似文献

相关主题

期刊订阅